 CAMBRIDGE, Mass.--BUSINESS WIRE--InVivo Therapeutics Holdings Corp. Nasdaq: NVIV, a research and clinical-stage biomaterials and biotechnology company with a focus on the treatment of spinal cord injuries, today announced that Richard Toselli, M.D., President and Chief Executive Officer, will present at the upcoming 2021 H.C. Wainwright Global Life Sciences Conference. The conference is scheduled to be held March 9-10, 2021 in a virtual format. Dr. Tosellis presentation will provide an ove 